TruthArchive.ai - Related Video Feed

Genes determine individual characteristics and their transmission to future generations. Evolution occurs when conditions produce structural gene changes. This can happen through selective mating, where a superior gene type effectively transmits itself. Gene drift, where some genes fade while others persist, is another mechanism. Natural selection filters genes based on their ability to endure in the environment. These processes may lead to the origin of entirely new species.

CRISPR, a lab technique, can alter mosquito DNA to decrease their population or prevent them from carrying parasites. Discussions are underway with African countries to determine the necessary tests and trials before implementing this technique. Although it will take several years to obtain country approvals, the potential to reduce mosquito populations and eliminate malaria locally is promising. The speaker even brought some mosquitoes to the auditorium to provide firsthand experience. They emphasize that it is unfair for only poor people to face this issue.

Every day, just the 1% of the cells of your DNA that gets replicated stretches from here to the sun four times. If you're to line it up end by end, that's very hard to conceptualize. But it should give you a little bit of humility before you go and start monkeying with it with these vaccines that can actually alter your DNA. And that's what I'm gonna show you. Is that the vaccines had a DNA contamination in them that didn't tell you about that could in fact alter your genome. Alright? These people are vibe coding your genome. And this is a major attack surface to the human gene pool because if this thing starts to alter the lifespan of people, it's going to part you with your Bitcoin. You're gonna end up spending money in a fiat system that has no controls, has no liability, and ends up oftentimes inducing mandates to get what it wants done. Many people had have peer have gone and replicated this work. It happened on Twitter. It did not happen very quickly in the peer review system. The peer review system kinda kicked it out. Some of these papers have now been peer reviewed, but it took years for them to come to this conclusion. Now, the FDA, the EMA and the TGA have all admitted that this mistake has happened. How did it happen? There's a big bait and switch. Pfizer actually ran the trial of 22,000 people on the process on the left and after they got to the trial, they then switched to the process on the right and didn't retrial the drug. And in doing so, they left a tremendous amount of excess DNA behind in the product. So all of the vaccine efficiency numbers you've heard in the news are flawed. They're not real because that's not what actually went into the trial. What went to the public was actually something that came out of this process too. It's published now in the BMJ that this fraud happened and no one has yet been prosecuted for it. So what did they leave in there? What they left in there was something we know from the polio scandal. If you're not familiar with the polio scandal, that polio vaccines were also contaminated with something known as SV40 and it created a massive cancer wave. Now the whole virus isn't in these vaccines, but there is a very curious part of this called the SV40 region that Pfizer intentionally removed from the disclosure that they gave to the FDA. So the FDA has admitted that this SV40 material is in there. They did not spell this out to the regulators. The regulators did not find them and they're actually running cover for them saying this DNA is too little consequence to matter, it's too small, and it's not functional. But we know it's functional because Dean et al has published that this piece of DNA drives DNA straight to the nucleus. It gets used in gene therapy vectors.

The symposium covers the potential safety and threat of “replicating” vaccines, especially LepriCon (leprecon) vaccines, in the context of Covid-19 vaccines and genome‑editing concepts. The speakers present a chain of claims and concerns, some drawing on reports and others presenting theories about how these next‑generation vaccines could behave in humans and populations. Key points and claims presented - Emerging mechanisms and risks: The panel notes that blood vessel inflammation and thrombosis mechanisms are increasingly observed, including in vaccine contexts, with examples from individuals who needed limb amputation and others who developed severe vascular events after vaccination. One case involved a 70‑year‑old man who, after a third dose, developed embolic events necessitating shoulder joint surgery, and another where a 60‑year‑old man developed acute limb ischemia and died; both are presented as suggesting a serious vascular mechanism linked to vaccination, though causal connections are not established. - Replicating/vector vaccines and their concerns:荒川博士 and others discuss LepiCon vaccines as vaccines that replicate inside the body. The concept involves “replicating viral vectors” where the genome can mutate and evolve during replication. The green‑highlighted segment in a slide (the antigen gene) plus a blue/orange segment (replicating gene cassette) is used to describe how LepriCon vaccines are designed to carry viral genes and replicate, with the assertion that replication, mutation, and recombination can occur, potentially generating new variants inside the host. - Differences from conventional vaccines: The discussion contrasts LepriCon vaccines with standard mRNA vaccines. In conventional mRNA vaccines, messenger RNA is delivered and translated into antigen proteins, then degraded; in LepriCon vaccines, replicating RNA/DNA can persist and continue producing antigen, with mutation and recombination possible. The panel emphasizes that LepriCon vaccines use replicating/copying mechanisms and that the genetic material can be copied in ways that differ from natural human biology, potentially creating unpredictable variants. - Central dogma and exceptions: The speakers reference the central dogma (DNA → RNA → protein) but note exceptions in viruses, including RNA viruses that can reverse‑transcribe to DNA (retroviruses) and RNA viruses that replicate RNA directly. They discuss how LepriCon vaccines would rely on replicative processes that do not follow the usual linear flow and why this could complicate predictions about safety and behavior in humans. - Potential for unintended spread and environmental impact: A major concern raised is that self‑replicating vectors could spread beyond the vaccinated individual, via exosomes or other intercellular transport, creating secondary infections or non‑target spread. Exosomes could ferry replicating genetic material, raising fears of new infection chains or “outbreaks” stemming from the vaccine itself, and even suggesting the possibility of vaccination‑induced spread akin to an attenuated or modified pathogen. - Safety signals and immunology concerns: The discussion touches on immune system risks, including immune dysregulation, autoimmune phenomena, and unexpected inflammatory responses. IGG4‑related disease is highlighted as a potential adverse outcome post‑vaccination, with descriptions of glandular and systemic involvement and the idea that high IGG4 levels could have immunosuppressive effects that alter responses to infection or vaccination. The panel notes observed increases in certain immunoglobulin subclasses after multiple LepriCon doses and discusses the possibility of immune tolerance or enhanced immune responses that could be harmful. - Historical and theoretical context: References are made to past epidemics and speculative pandemics caused by misused or dangerous vaccine platforms, drawing on central molecular biology concepts and historical anecdotes about how vaccines can be designed and misused. The discussion frames LepriCon vaccines as a high‑risk platform that could, in theory, generate recombinants, escape mutations, or cause unintended immune and inflammatory consequences. - Clinical and regulatory implications: The speakers call for caution, arguing that more evidence is needed before approving or widespread use of LepriCon vaccines. They emphasize the need for long‑term observation and transparent communication about risks, and criticize the potential for insufficient understanding among healthcare workers and the public. They also urge that any future vaccine development should consider the possibility of genome editing, recombination, and exosome‑mediated spread, and stress the importance of not underestimating possible adverse effects. - Real‑world observations and skepticism about hype: Several speakers underscore that the danger is not merely hypothetical; there are reports of adverse events, including stroke‑like conditions, inflammatory diseases, and immune dysregulation in vaccinated individuals. They stress that the evolution and mutation of replicating vaccines could outpace current surveillance methods, and that “information manipulation” or lack of transparent reporting could mislead the public about risks. - Final reflections and call to action: The concluding messages advocate recognizing the potential failures of messenger RNA vaccines and acknowledging that both conventional and replicating platforms may carry risks. The speakers urge ongoing critical analysis, cautious progression, and robust verification of claims through transparent, independent investigation. They close with thanks to the organizers and a hope that the discussion may contribute to broader public awareness and informed decision‑making. Notable emphasis and unique considerations - The core concern centers on LepriCon vaccines’ replication, mutation, and potential to spread beyond the vaccinated person; exosome transport and genomic/cellular integration are highlighted as mechanisms that could generate new risks not present with non‑replicating vaccines. - The discussion stresses that IGG4 responses could become alarmingly high after certain doses, potentially leading to immunosuppressive effects or autoimmune phenomena, and presents IGG4‑related disease as a potential complication to monitor. - The speakers insist that safety and transparency are paramount, and that misinformation or optimistic narratives about rapid vaccine development could lead to harm if new platforms are adopted without comprehensive evaluation. Overall, the symposium foregrounds cautious scrutiny of replicating vaccine platforms, frames potential biological and regulatory risks, and calls for careful, evidence‑based assessment before broader deployment.

We are discussing regulation and the use of CRISPR to reduce mosquito populations and combat malaria. We are working with African countries on necessary trials. It will take time to get approvals, but the potential to eliminate disease locally is promising. Malaria is transmitted by mosquitoes, and we are demonstrating this by releasing some in the auditorium. Everyone should understand the impact, not just the poor.

There is a technique called CRISPR in the lab that can manipulate mosquito DNA to reduce their population or eliminate the disease they carry. Discussions are ongoing with African countries to determine the necessary tests and trials before implementing this solution. However, obtaining country approvals will take several years. Despite the time frame, the potential of reducing mosquito population and eradicating the disease locally makes this approach highly promising.

The secret of life lies hidden in the genetic code. Genes determine individual characteristics and pass them to future generations. Occasionally, conditions produce a structural change in the gene, bringing about evolution. This may occur through selective mating, where a single gene type proves superior in transmitting its genes. Gene drift can also cause certain genes to fade while others persist. Natural selection filters out genes better equipped to endure in the environment. This may result in the origin of an entirely new species, which brings us to Calvin's and the survival of the fittest. Calvin Klein jeans.

Checklist for summary approach: - Identify and preserve the core claims about GMO technology, safety concerns, and corporate motives as presented. - Highlight explicit examples and mechanisms (insertion of genes, Bt toxin, built-in pesticides, herbicide tolerance, seed patents). - Note the portrayed regulatory and legal dynamics (lobbying, revolving door, labeling, litigation, seed saving restrictions). - Emphasize unique or provocative elements (codfish gene for frost resistance, Indian BT cotton suicides link, cross-pollination as “not our problem”). - Exclude repetitive or filler content; avoid adding new judgments or opinions. - Translate or retain English phrasing of key statements exactly as needed. - Keep the summary within 388–486 words. Genetically modified organisms (GMO) are presented as a comprehensive, almost omnipotent solution to modern nutrition and farming, combining inserted insect and fish genes, irradiation, and pesticides embedded in crops. The narrative asserts: “Our GM scientists are putting the pesticide right inside the crops,” so the food itself will “kill those pesky critters stone cold dead.” It claims Bacillus thuringiensis (Bt) toxin, produced by the inserted gene, destroys insects’ stomachs but not humans, adding, “We have absolutely no testing results to prove that these are safe, but they are. Trust us.” It argues that pesticides in crops enable plants to withstand more weed killer than organic crops, promising “No weeds, no bugs. More food, more profit.” The transcript lists staple crops: corn, rice, soybeans, cotton, alfalfa, papaya, oilseed rape, and adds that “GM is the gift that keeps on giving,” with ambitions including frost-resistant traits such as codfish genes in strawberries for the icy North Atlantic environment: “insert a gene from a codfish… Result, frost resistant strawberries.” It frames the looming challenge of population growth and food security as justification for rapid GMO adoption. Testing anecdotes are cited: “tests on rats eating genetically modified potatoes showed them growing slower after two or three generations and developing fertility problems, some organ development issues.” The speakers disparage critics as “goody two shoes scientists” and “whiny campaigners,” insisting they will wait to see human effects while biotech profits fund further GMO experiments. A central strategy is to persuade farmers to abandon organic farming in favor of GM, accompanied by aggressive seed patenting: “Whenever we change the natural gene sequence of any plant, we get a patent ASAP. It’s our invention after all. … total control of the seed.” Seed saving would be prohibited: “If you save seeds for next year’s crop, we’ll know. We’ll tie up farmers for years in the courts.” Farmers must buy new seeds and pesticides yearly; cross-pollination is dismissed as not their problem, and “your crops belong to us” once genes migrate. Regulatory capture and lobbying are described as routine: a “revolving door” between industry and judges, former GM lawyers in regulation bodies, and efforts to keep GMO labeling off products. The piece notes India’s BT cotton saga, claiming “hundreds of thousands of farmers have been organically recycled to dodge debts that they owe us,” with debts supposedly dying with farmers under Indian law and Bt cotton’s yields and bollworm resistance threatening revenue, as the strategy envisions becoming the sole cotton-seed supplier. European concerns about GMO pig feet—sterilization and growth issues—are acknowledged, with plans to work around them. The closing pitch invites consumption: “Eat up your veggies… there’ll be plenty for everyone for the right price.”

Scientists plan to introduce a hundred mammoth-like creatures into a Siberian park to study the impact of megafauna on Arctic tundra carbon emissions. They are creating these animals by combining elephant and mammoth DNA using CRISPR technology. The process involves taking Indian elephant DNA and filling in the missing fragments of mammoth DNA to create an embryo. This embryo is then implanted into an Indian elephant, which will give birth to an animal physically identical to a mammoth after a twenty-two-month gestation period. The resulting animal is not a hybrid, but rather a mammoth created using the closest living relative's DNA to complete the genome.

Genetically modified mosquitoes approved for release in the US mate with females, causing their offspring to die. The program aims to vaccinate people without consent by using mosquitoes as "flying syringes." Concerns arise from the use of partially true narratives to introduce GMO insects, with potential implications for involuntary vaccinations.

Gene p53, the "guardian of the genome," identifies DNA damage in cells and either repairs the damage or destroys the cell. However, p53 is mutated in over half of all human cancers. This allows cells with damaged DNA to continue dividing, which initiates and spreads cancer. The proper function of p53 can be life-saving, while its dysfunction gives cancer a head start.

Life is hidden in the genetic code, and genes determine individual characteristics passed to future generations. Evolution occurs when conditions cause structural gene changes. This happens through selective mating, where a superior gene type transmits genes to future generations; gene drift, where some genes fade while others persist; and natural selection, which filters genes based on their ability to endure in the environment. This process can lead to the origin of new species, relating to the concept of survival of the fittest.

Malaria eradication is challenging, but gene drive technology could change the genetics of mosquitoes to help achieve this goal. Mosquitoes can be genetically modified to act as "flying syringes" that deliver malaria vaccines when they bite humans. However, there are concerns about the potential risks of spreading malaria and the ethical implications of genetically modifying mosquitoes without informed consent. Despite these concerns, the development of new tools and technologies is crucial for malaria eradication.

Spend all this money so that your apple wouldn't brown when sliced. So this non browning apple and non browning potato uses something called double stranded RNA. A little piece of RNA is created in these crops that silence the gene that normally causes the browning. Now, many scientists all over the world are concerned that that little snippet that we eat might reprogram or silence our DNA. Over a period of the next few weeks, over 1,400 genes change levels of expression compared to those that didn't have that meal. So that's 10% of the genome. We also know that certain mice can change their gene expression when they are eating double stranded RNA. And in spite of those peer reviewed published studies, the USDA allowed it on the market.

This precision tool introduces a protein RNA complex into cells or tissues to correct mutations. The complex can be injected into fertilized eggs, such as those of a mouse. In an experiment targeting the gene for black coat color, edited eggs implanted in a female mouse resulted in mostly white pups. These mice have a single genetic change in every cell, giving rise to the white coat color, but are otherwise normal. This type of experiment used to take at least a year; now it can be done in a few weeks. The technology has seen exponential growth in publications and is being used for targeted genetic changes in plants, fungi, and animals important agriculturally or as pets. It's also being used to make changes in stem cells and in animal models of human disease, with the possibility of making changes in humans in the future.

GMOs, or genetically modified organisms, were once believed to be a solution for world hunger, promising benefits like drought resistance, higher yields, improved nutrition, and reduced pesticide use. However, the reality is quite different. The majority of GMOs on the market today serve two purposes: producing insecticides within the plant itself and being resistant to herbicides. This means that bugs that consume these plants die, and the plants can be sprayed with toxic herbicides without being harmed. Consequently, we are now consuming plants that act as pesticide factories and have been exposed to herbicides.

CRISPR is a molecular tool that allows for precise genetic editing. Since its introduction in 2012, it has been used to modify various species, including potentially spreading alterations through wild organisms. Malaria is a highly destructive disease, causing the death of 400,000 children annually. Scientists propose using CRISPR to disable or eliminate the mosquito species that transmit malaria, as it is a more effective solution than widespread DDT spraying. Despite potential risks, the severity of malaria outweighs any possible negative consequences, making it a worthwhile endeavor.

Alden and colleagues found that Pfizer's genetic code can be integrated into the human genome within an hour in a cancerous cell line. This suggests that Pfizer and Moderna's genetic material might become a permanent part of human DNA. There is no study confirming or denying this possibility. The concern is that if eggs or sperm incorporate this genetic code, it could be passed on to future generations. This lack of research is seen as reckless and worrisome.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

Genes determine individual characteristics and pass them to future generations. Structural gene changes can lead to evolution through selective mating, where a superior gene type transmits itself more effectively. Gene drift can also cause evolution, with some genes fading while others persist. Natural selection filters genes based on their ability to endure in the environment. These processes may result in the origin of a new species, relating to the concept of survival of the fittest.